NCT05882500

Osteopontin as a Biomarker in Pancreatitis

Osteopontin and Other Potential Biomarkers and Factors Important for Prognosis in Pancreatitis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 103 (actual)
• Sponsor: Linkoeping University · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis.

Detailed description

In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis. Patients admitted and diagnosed with pancreatitis (according to the Atlanta criteria) will have serial testing of se-osteopontin in addiation to rutine blood work. Computet tomograpy and chest x-ray are mandatory as is blood culture.

Conditions

• Pancreatitis

Interventions

Type	Name	Description
OTHER	No intervention, observation

Timeline

• Start date: 2011-03-03
• Primary completion: 2016-10-19
• Completion: 2023-01-31
• First posted: 2023-05-31
• Last updated: 2023-05-31

Locations

1 site across 1 country: Sweden